Vice President, Clinical Operations and Program Management
Ratio Therapeutics
Christine Redmond, MPH is the Vice President, Clinical Operations & Program Management at Ratio Therapeutics. Christine holds an BA in Biology from Wheaton College (MA) and an MPH in epidemiology from University of Massachusetts, Amherst. Christine has several decades of drug development experieince and has held strategic leadership roles in Portfolio/Program Management and Clinical Operations at the Bill & Melinda Gates Medical Research Institute, Biogen, Synta, Lantheus, Molecular Insight Pharmaceuticals, Dyax, and Acorda Therapeutics.